Drug adverse event reports (FAERS)
Reports of adverse events and medication errors sent to FDA for drugs and therapeutic biologics. 21,054,159 records; openFDA updated it 2026-11-09. About this dataset
Newest records
- DRUG INEFFECTIVE1,319,277
- OFF LABEL USE876,512
- DEATH862,365
- NAUSEA792,262
- FATIGUE779,382
- DIARRHOEA646,144
- HEADACHE627,598
- PAIN614,895
- Loss of personal independence in daily activities, Adverse event, Condition aggravated +2
Drugs: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE
- Product storage issue, Product dose omission issue
Drugs: TREMFYA
- Skin discolouration, Pigmentation disorder
Drugs: PEMETREXED DISODIUM, CARBOPLATIN
- Product dose omission issue, Drug ineffective
Drugs: BIMZELX
- Apparent death, Joint swelling, Urticaria +28
Drugs: HUMIRA, REMICADE, RITUXAN +22
- Death
Drugs: OLAPARIB
- Nasopharyngitis
Drugs: JUBBONTI
- Neutropenia
Drugs: IBRUTINIB, EPIRUBICIN, ESTRAMUSTINE +64
- Neutropenia
Drugs: IBRUTINIB, VANDETANIB, PANOBINOSTAT +65
- Heart rate irregular, Jaw cyst, Hypersensitivity
Drugs: RAVULIZUMAB
- Chronic lymphocytic leukaemia recurrent, Drug interaction
Drugs: ACALABRUTINIB
- Product delivery mechanism issue, No adverse event
Drugs: ALBUTEROL SULFATE
- Off label use
Drugs: TREMFYA
- Poor quality product administered, Feeling abnormal
Drugs: TREMFYA
- Fall, Off label use
Drugs: LUMAKRAS
- Somnambulism, Extrapyramidal disorder
Drugs: DEPAKOTE, ARIPIPRAZOLE, MIRTAZAPINE +1
- Off label use
Drugs: ELIQUIS
- Anaemia, Renal impairment, Insurance issue +4
Drugs: OLAPARIB
Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.
How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.